Literature DB >> 19011400

Digoxin: current use and approach to toxicity.

Rey P Vivo1, Selim R Krim, Joanne Perez, Mahakit Inklab, Thomas Tenner, John Hodgson.   

Abstract

Heralded as the oldest known cardiovascular drug, digoxin remains widely used today in the face of increasing rates in heart failure and atrial fibrillation despite the emergence of newer medications. Its hemodynamic, neurohormonal and electrophysiologic actions make it a suitable adjunctive, evidence-based therapy for the above conditions. Its narrow therapeutic index and its toxicity, however, have become more relevant as aging, comorbid diseases, and polypharmacy make more patients vulnerable. Because signs and symptoms of digoxin toxicity are mostly nonspecific, a high index of suspicion is crucial for early recognition and appropriate management.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19011400     DOI: 10.1097/MAJ.0b013e318176b94d

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  7 in total

1.  Tablet splitting of narrow therapeutic index drugs: a nationwide survey in Taiwan.

Authors:  Chia-Lin Chou; Chia-Chen Hsu; Chia-Yu Chou; Tzeng-Ji Chen; Li-Fang Chou; Yueh-Ching Chou
Journal:  Int J Clin Pharm       Date:  2015-09-23

Review 2.  Active ingredients in Chinese medicines promoting blood circulation as Na+/K+ -ATPase inhibitors.

Authors:  Ronald J Y Chen; Tzyy-rong Jinn; Yi-ching Chen; Tse-yu Chung; Wei-hung Yang; Jason T C Tzen
Journal:  Acta Pharmacol Sin       Date:  2011-02       Impact factor: 6.150

3.  Emergency department visits and hospitalizations for digoxin toxicity: United States, 2005 to 2010.

Authors:  Isaac See; Nadine Shehab; Scott R Kegler; S Raja Laskar; Daniel S Budnitz
Journal:  Circ Heart Fail       Date:  2013-12-03       Impact factor: 8.790

Review 4.  Computational Modeling of Electrophysiology and Pharmacotherapy of Atrial Fibrillation: Recent Advances and Future Challenges.

Authors:  Márcia Vagos; Ilsbeth G M van Herck; Joakim Sundnes; Hermenegild J Arevalo; Andrew G Edwards; Jussi T Koivumäki
Journal:  Front Physiol       Date:  2018-09-04       Impact factor: 4.566

5.  Search for Natural Compounds That Increase Apolipoprotein A-I Transcription in HepG2 Cells: Specific Attention for BRD4 Inhibitors.

Authors:  Sophie E van der Krieken; Pieter C van-der Pijl; Yuguang Lin; Herman E Popeijus; Ronald P Mensink; Jogchum Plat
Journal:  Lipids       Date:  2019-12-08       Impact factor: 1.880

6.  Probing the stereoselectivity of OleD-catalyzed glycosylation of cardiotonic steroids.

Authors:  Xue-Lin Zhu; Chao Wen; Qing-Mei Ye; Wei Xu; Deng-Lang Zou; Guang-Ping Liang; Fan Zhang; Wan-Na Chen; Ren-Wang Jiang
Journal:  RSC Adv       Date:  2018-01-30       Impact factor: 4.036

7.  A 5 Years Assessment of Patients with Acute Digoxin Poisoning: A Toxicoepidemiology Study in Iran.

Authors:  Mitra Rahimi; Arezou Mahdavinejad; Shahin Shadnia; Ali Saffaei
Journal:  Heart Views       Date:  2022-02-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.